Purchases and Sales Made in Q3 2022 in Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP) during Q3 2022. The information is specifically focused on institutions that hold shares of CRISPR Therapeutics AG.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 09, 2022
Q3 2022
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-129K- 94.96% |
$7.88M - $10.8M
|
6.85K
$274K
|
|
|
Nov 14, 2022
Q3 2022
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-133K- 89.61% |
$8.11M - $11.1M
|
15.4K
$615K
|
|
|
Nov 14, 2022
Q3 2022
|
Valiant Capital Management, L.P.
San Francisco, CA |
SELL
|
- |
-134K- 41.26% |
$8.16M - $11.2M
|
190K
$7.61M
|
|
|
Nov 14, 2022
Q3 2022
|
Loomis Sayles & CO L P
|
SELL
|
- |
-151K- 10.82% |
$9.23M - $12.7M
|
1.25M
$49.8M
|
|
|
Nov 14, 2022
Q3 2022
|
American Century Companies Inc
Kansas City, MO |
SELL
|
- |
-201K- 95.84% |
$12.3M - $16.8M
|
8.71K
$349K
|
|
|
Oct 14, 2022
Q3 2022
|
Green Alpha Advisors, LLC
|
SELL
|
- |
-201K- 87.97% |
$12.3M - $16.8M
|
27.5K
$1.1M
|
|
|
Nov 14, 2022
Q3 2022
|
Nikko Asset Management Americas, Inc.
|
SELL
|
- |
-321K- 7.01% |
$19.6M - $26.9M
|
4.26M
$171M
|
|
|
Oct 21, 2022
Q3 2022
|
Sumitomo Mitsui Trust Holdings, Inc.
|
SELL
|
- |
-321K- 7.01% |
$19.6M - $26.9M
|
4.26M
$171M
|
|
|
Nov 14, 2022
Q3 2022
|
Pictet Asset Management Sa
Geneva 73, V8 |
SELL
|
- |
-387K- 91.42% |
$23.6M - $32.4M
|
36.3K
$1.45M
|
|
|
Oct 17, 2022
Q3 2022
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
SELL
|
- |
-1.49M- 15.32% |
$91.1M - $125M
|
8.24M
$329M
|
|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.83M- 60.61% |
$112M - $153M
|
1.19M
$47.5M
|